A3P Biomedical Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 30

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Latest Deal Amount
  • $6.64M

  • Investors
  • 4

A3P Biomedical General Information

Description

Developer of a blood-based diagnostic screening test designed to improve early detection and risk stratification of aggressive prostate cancer. The company offers a clinically validated algorithm that integrates protein biomarkers, genetic markers, and clinical data, enabling healthcare providers to identify men at risk of clinically significant prostate cancer with improved accuracy.

Contact Information

Website
www.a3p.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Kungsgatan 24
  • 111 35 Stockholm
  • Sweden
+46 010-182
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Corporate Office
  • Kungsgatan 24
  • 111 35 Stockholm
  • Sweden
+46 010-182

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

A3P Biomedical Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 06-Mar-2025 $6.64M Completed Generating Revenue
3. IPO Cancelled Generating Revenue
2. Early Stage VC 05-May-2022 $41.5M $53.9M Completed Generating Revenue
1. Early Stage VC 21-Oct-2020 $12.4M $12.4M Completed Startup
To view A3P Biomedical’s complete valuation and funding history, request access »

A3P Biomedical Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preference
To view A3P Biomedical’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

A3P Biomedical Patents

A3P Biomedical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4195211-A1 Certainty estimation in medical measurements Pending 08-Dec-2021
US-20230178251-A1 Certainty estimation in medical measurements Inactive 08-Dec-2021
EP-4195212-A1 Certainty-based medical conclusion model adaptation Pending 08-Dec-2021
US-20230187081-A1 Certainty-based medical conclusion model adaptation Inactive 08-Dec-2021
AU-2022354579-A1 Method and system for management of medical care resources Inactive 01-Oct-2021 G16H10/40
To view A3P Biomedical’s complete patent history, request access »

A3P Biomedical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

A3P Biomedical Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Inbox Capital Venture Capital Minority
Östersjöstiftelsen Limited Partner Minority
Stena Sessan Limited Partner Minority
TomEqt Private Venture Capital Minority
To view A3P Biomedical’s complete investors history, request access »

A3P Biomedical Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
A23 Lab Uppsala, Sweden 2018

A3P Biomedical FAQs

  • When was A3P Biomedical founded?

    A3P Biomedical was founded in 2018.

  • Where is A3P Biomedical headquartered?

    A3P Biomedical is headquartered in Stockholm, Sweden.

  • What is the size of A3P Biomedical?

    A3P Biomedical has 30 total employees.

  • What industry is A3P Biomedical in?

    A3P Biomedical’s primary industry is Diagnostic Equipment.

  • Is A3P Biomedical a private or public company?

    A3P Biomedical is a Private company.

  • What is A3P Biomedical’s current revenue?

    The current revenue for A3P Biomedical is .

  • How much funding has A3P Biomedical raised over time?

    A3P Biomedical has raised $53.9M.

  • Who are A3P Biomedical’s investors?

    Inbox Capital, Östersjöstiftelsen, Stena Sessan, and TomEqt Private have invested in A3P Biomedical.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process